The sports technology market size is expected to grow by USD 24.56 bn from 2021 to 2026. The market is expected to record a year-over-year growth rate of 21.48% in 2022.

The sports technology market has been segmented by technology into three segments, namely AI ML, IoT, and AR VR. By technology, the AI ML segment will have significant market share growth during the forecast period. AI can perform automated tasks, assist in performing tasks efficiently and quickly, help with better decision-making, and automate decision-making processes.

Read more: WHOOP Acquires Sports Tech Startup PUSH To Unlock Deeper Strength-Training Insights

Some of the primary growth drivers for the sports technology market are the rising number of sports technology events, the launch of new platforms, and growing participation in sports tournaments, according to a senior analyst at Technavio. The market forecast reports by Technavio help organizations make confident business decisions with the help of thorough research and expert analysis, says a press release.

Vendor Offerings

• Agile Sports Technologies Inc. - The company offers Volleymetrics that can record and upload analytics with automatic smart cameras and saves time.
• Athlete Intelligence - The company offers VECTOR MouthGuard which is a highly accurate head impact monitoring wearable device for team contact sports.
• Catapult Group International Ltd. - The company offers wearable technology such as Catapult Vision which brings pre- and post-match analysis and Catapult AMS which elevates the management and communication of data.
• Chetu Inc. - The company offers sports analytics and athlete performance solutions that build a suite of sports analytics tools designed for ultimate performance intelligence.
• Cisco Systems Inc. - The company offers sports technology such as Esports.

Regional Analysis

• Based on geography, the sports technology market has been segmented into five regions, namely North America, Europe, APAC, South America, and MEA.
• 43% of the growth is expected to originate from North America.
• The US and Canada are the key countries for the sports technology market in North America.
• Market growth in this region will be faster than the growth of the market in North America, Europe, APAC, South America, and MEA.
• The launch of innovative and improved sports technology products and platforms, growing Internet penetration, and the launch of advanced video game consoles will drive the growth of the sports technology market in North America during the forecast period.

Notes:

• The sports technology market size is expected to accelerate at a CAGR of 23.09% during the forecast period.
• The market is fragmented due to the presence of many vendors holding significant market shares.
• The research report offers information on several market vendors, including Agile Sports Technologies Inc., Athlete Intelligence, Catapult Group International Ltd., Chetu Inc., Cisco Systems Inc., Epicor Software Corp., Firstbeat Technologies Oy, International Business Machines Corp., Jonas Club Software, and SAP SE.

Read more: Tokyo Olympics: Indian Olympic Association acquires Dhyana Rings For Its Athletes To Improve Mental Wellness

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Hapbee Technologies, the smart wearable, wellness technology company today announced three special holiday-themed blends that can be enjoyed through the Hapbee smart wearable device and app.

Grounded in science, the Hapbee Smart Wearable is designed to help people find calm, improve focus, sleep, and performance. The new blends were designed with the holidays in mind – time for recuperation, festive gatherings, and family get-togethers.

Read more: Hapbee Launches New “Boost” Signal To Provide Users With Caffeine-Free Energy Boost

"Getting into the holiday spirit can be a struggle for some and Hapbee is there to lend a helping hand – without the unwanted side effects of ingesting a stimulant," said Yona Shtern, CEO of Hapbee. "Hapbee helps people control how they want to feel, sleep, create and play. A series of Holiday Blends seemed like the perfect gift to offer to our community of subscribers combined with our smart wearable innovation."

Hapbee subscribers will now be able to choose from a total of 22 signature lifestyle blends and will automatically receive the new holiday blends when they update the Hapbee App to the latest release – free for download from the App Store and Google Play, the company said in a press release.

Overview of New Holiday Blends:

• Winter's Nap: An engineered blend derived from digital Melatonin and CBD.
• Set the timer for 30 minutes for a cat nap between chores or for 2 hours for a power snooze before the big game or an outing with friends.
• Oh Joy: An engineered blend derived from digital caffeine and alcohol

• Ring in the holiday season with a digital boost of fun and frolic. No need to open a bottle to feel the warm rush of merriment. Just dial into this fun blend combining some of your favorite "refreshers" without any of the side effects.
• Family Time: An engineered blend derived from digital CBD and alcohol
• Climb into the right state of relaxation that will make hours with family (especially in-laws) melt away. Blended to help you take the edge off and ensure this holiday season is the chilliest one yet.

Read more: Nano membrane Wearable Sensors Deliver Precision and Continuous Stress Monitoring

About Hapbee

Hapbee is an innovative wearable wellness technology company that helps people enhance how they feel. Powered by patented ultra-low radio frequency energy (ulRFE) technology, Hapbee delivers low-power electromagnetic lifestyle blends designed to produce sensations such as Happy, Alert, Focus, Relax, and others. The Company has offices in Montreal, Vancouver, Seattle, and Phoenix.

Medical devices company, Sky Medical Technology Ltd, received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the geko™ device for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency and/or ischemia.

Read more: Monash University Researchers Develop Wearable Blood Pressure Monitor

The geko device is the first electrical neuromuscular stimulator of its kind to be cleared for increasing microcirculatory blood flow and adds to Sky's prior FDA clearances for edema reduction and for stimulation of the calf muscles to prevent venous thrombosis (blood clots) in both surgical and non-surgical patients.

Venous insufficiency and ischemia relate to reduced blood flow in the veins and arteries. This can lead to lower extremity edema, skin changes, and discomfort. Venous insufficiency can progress to chronic venous insufficiency (CVI), a serious condition attributed to diminished quality of life and loss of work productivity. In most cases, the cause is incompetent valves. Each year approximately 150,000 new patients are diagnosed with chronic venous insufficiency, and nearly $500 million is used in the care of these patients. If venous insufficiency and ischemia are left untreated, progressive CVI can lead to post-phlebitic syndrome and venous leg ulcers, the company said in a press release.

Three recently published studies, two led by Das, and the other led by Bosanquet demonstrate geko device-generated microcirculatory blood flow increase in the lower limbs of patients with venous insufficiency and ischemia. Both studies measured the increase using Laser Speckle Contrast Imaging, a non-invasive technique that measures blood flow.

CEO and Founder Bernard Ross said, "Achieving this latest 510(k) clearance is a significant milestone for Sky that will allow us to initiate a controlled market release of the geko device, to address venous insufficiency and ischemia in the first instance – a therapy area sorely in need of innovation. With this 510(k) and in partnership with leading US clinicians we can now press ahead to redefine the way vascular-related conditions can be treated."

The geko device is a non-invasive, easy-to-use, wearable therapy device. The size of a wristwatch and worn at the knee, the disposable device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf, at a rate equal to 60%6 of walking without a patient having to move. The device operates without external pressure to the leg and allows complete mobility.

Read more: This “Smart Stent” Can Monitor Blood Flow and Detect Narrowing of Artery

The company is headquartered in the UK and backed by leading international investors in both healthcare and technology. The company is in the process of submitting further FDA 510(k) applications to expand its claims related to blood flow increase to address venous insufficiency.

About Sky Medical Technology Ltd and Firstkind Ltd

Sky Medical Technology, the parent of Firstkind Ltd, is a UK-based medical devices company. Through its innovative mechanism of non-invasive neuromuscular electrostimulation, Sky has developed a ground-breaking NMES technology platform, OnPulse, embedded in its industry-leading product, the geko device. The company develops a range of products tailored to the needs of different medical application areas, selling both direct and through strategic partnerships or distributors in each major clinical area. Clinical areas of interest include DVT prevention, the treatment and reduction of edema, and venous insufficiency. The goal in each pathway is to partner with healthcare professionals to improve clinical outcomes and patient care whilst saving health system resources.

World famous Metaverse builder MetaEstate officially promulgated integrated planning of Satoshi island in Cryptovoxels metaverse. According to the plan, the island shall be divided into four areas by two central axis lines in Satoshi island as split lines, thus building high-end residences, a fund town, leisure and entertainment, and an art town. Based on the increasing market demand for Metaverse, MetaEstate will reasonably regulate land use, build premium architecture, introduce prestigious IP, exploit usage scenarios, implement marketing promotion, and so on to activate and enrich four areas, therefore forging Satoshi island into one of "Digital Utopia" series towns.

Read more: Will Combined Power of 5G and Artificial Intelligence Change Tech Innovations of Tomorrow?

In the world of Cryptovoxels, Satoshi island is located on the northwest side of Origin City, with its axis 700W, 350N in the center, whose island is 33658 square meters and owns 357 plots. The data from k1ic.com shows that the average land price of Satoshi island has reached 0.0194 ETH/㎡, ranking top among average prices in Cryptovoxels. Moreover, the total value of Satoshi island has as well reached 653.9 ETH, following Origin City. These figures prove Satoshi island in the Cryptovoxels world is the most sought-after and most heated-bidding area. Up to now, enterprises and institutions like RocketDollar, Cryptomeria Captial, Waterdrip Capital, Deeper Network, CryptoArt.Ai, and so on have already settled down in Satoshi island.

Integrated planning of Satoshi island

The northwest area of Satoshi island belongs to the high-end residence, having been built with high-end villas including Jupiter, Mercury, Venus, Mars, and Saturn. In the future, MetaEstate shall construct more smart living housing of Metaverse and related living facilities architecture, ingenious design, or architectural aesthetics leading the Metaverse world.

The southwest area of Satoshi island belongs to the fund town and its headquarters. Various famous funds and institutions have been introduced to settle in like RocketDollar, Cryptomeria Captial, Cryptogram Venture, Waterdrip Capital, Blueberry Labs HQ, NFT Lion Cubs, ME HQ, MerkleTree, and so on, this area is planned to become a well-known financial and enterprise block in Metaverse.

The northwest area of Satoshi island belongs to leisure and entertainment. So far this area has already constructed facilities including Street Art Social Club, Klay Ape Club, THE CROWD, with playing and leisure functions offered by this area. In the coming days, the buildings here will manifest the abstract imagination of the architects, more mutual and entertaining ways are waiting for explorers to experience them to their full extent.

The southeast area of Satoshi island belongs to an art town, with CLTR Gallery, Bored Mummy, METACHI Gallery, Ting Song Museum, and so on having settled in. In the future, there will be more and more galleries, exhibition halls, museums, and art sculptures to attract art lovers in the Metaverse to gather and create here.

"Digital Utopia" Plan

MetaEstate plans to forge Satoshi island into a comprehensive city among the whole Metaverse in the lead to meet all the demands of Satoshi residents and visitors. "Digital Utopia" series town including Satoshi island is a revolutionary experiment and has a profound influence on Metaverse's development.

As is known, later MetaEstate will officially promulgate the architectural planning of Miami island.

Read more: Apple Seeking to Boost Position in Augmented Reality Space, Buys AR Lens Startup

According to a report in August 2021, MetaEstate has bought in amounting to about 1.5 million dollars around 200 blocks in succession in Cryptovoxels Metaverse. Till now it increases its holding and is estimated to hold more than 400 blocks of Cryptovoxels Metaverse block. (According to statistics, the single address of Cryptovoxels Metaverse holding the number of Top 1 is only 169 blocks)

About MetaEstate

MetaEstate concentrates on offering Metaverse architecture service, absorbed in enriching content construction of Metaverse and thus reasonably regulating land use, building premium architecture, introducing prestigious IP, exploiting usage scenarios, implementing marketing promotion, and so on. Users can explore the Meteverse with the help of MetaEstate, including constructing all kinds of delicate architecture, customized wearable devices, and enjoying the service of property management.

Vayyar Imaging, the Israeli supplier of 4D imaging radar-based solutions, has teamed up with Amazon to make Vayyar Care, Vayyar's touchless fall detection solution, compatible with the new Alexa Together service from Amazon.

Read more: Cerna Home Care Releases “OnHand Assistance”, a Smartwatch for Seniors’ Safety

Wall-mounted sensors use point cloud imaging technology to constantly monitor their surroundings, providing peace of mind while respecting privacy. Vayyar Care detects falls in all lighting conditions, including pitch darkness, and even dense steam, making it ideal for use in bathrooms where 80% of falls happen and where customers may not want to have cameras.

After a fall, standard buttons and cords are often out of reach and even wearables cannot guarantee round-the-clock protection: a third of seniors forget to put on their devices, while a fifth refuse to use them, fearing loss of independence, a press release has said.

In fact, over 90% of seniors now prefer to continue to live independently rather than move into an assisted living community.

"We designed Alexa Together to help aging customers feel more comfortable and confident living independently," said Nicolas Maynard, Senior Manager of Amazon Alexa. "Alexa Together offers even more value for aging customers when they can connect a device like Vayyar Care. We're excited to team up with Vayyar Imaging to help give our customers added peace of mind.

When the Vayyar Care device detects a fall, it will send a signal to Alexa to ask if the customer wants to call the Alexa Together Urgent Response emergency helpline. Alexa will also send a notification to the aging loved one's caregiver.

"With today's seniors more empowered and engaged than ever, there's a clear need for smart technologies that enable them to maintain their lifestyles, providing the protection they demand and the peace of mind their families expect," said Raviv Melamed, Vayyar Co-founder and CEO. "That's exactly where Vayyar Care comes in, and I'm delighted that we're able to play a pivotal role in Amazon's new Alexa Together service."

Read more: Wearable Inertial Sensor-Based Devices Can Accurately Assess Elderly Fall Risk: Study

Vayyar Care builds on the global success of the company's B2B platform, which provides real-time fall detection and supports advanced activity analytics for senior living communities in the U.S., EU, China, Australia, and beyond.

The multifunctional sensing technology relies on low-power radio frequency waves, providing a safe, robust, and reliable solution for elderly people who want 24/7 protection without compromising their privacy or independence. Vayyar Care is available now from amazon.

Australian Telehealth firm Coviu said it will work on a project to create a new digital toolkit for telehealth wound care. The company is working in collaboration with the government research agency Commonwealth Scientific and Industrial Research Organization, the Western NSW Primary Health Network, university partners The University of Sydney and The University of Technology Sydney, and insurance firm Australian Unity.

Read more: Verizon BlueJeans Telehealth Integrates with Apple Health To Streamline Patient Care

The cost of chronic wounds is equivalent to more than $3.5 billion, approximately 2% of national healthcare expenditure, with more than 400,000 Australians estimated to suffer at any time.

The new suite of digital tools will provide a one-stop-shop for clinicians caring for wounds, which have become even more acute during the pandemic, especially in regional areas where there are workforce shortages.

Through AI-powered mobile imaging, physicians will be able to analyze and monitor wounds remotely.

Coviu has received roughly A$6.5 million ($4.5 million) in funding from the federal government's Medical Research Future Fund for this project, which will start development next year. Coviu targets to release its digital wound care toolkit on its platform in 2026, reports MobiHealthNews.

Commenting on the technology, Dr. Annie Banbury, Clinical Research Lead at Coviu said, “The wound care digital toolkit gives us an enormous opportunity to make a difference to the health and quality of life of aged care residents. It will support clinicians, such as GPs, to make data-informed clinical decisions for wound care during a telehealth video call. It will also allow more clinicians to provide high-quality wound care to residential aged care settings.  The toolkit will continue building Coviu’s AI digital tools to support health care providers”.

Read more: OCBC Bank Launches Healthcare App With Partners To Provide Access To Over 100 Telehealth Doctors

“The toolkit will bring together organizations with a range of expertise – from creating the AI solution with wound care experts to its implementation in residential aged care. For this project, we have Coviu, leading research institutions, aged care providers, and specialists in rural health and health economics. To have the backing of the Federal Government’s Medical Research Future Fund is fantastic – we can’t wait to get started.”

For years, the Oura Community has been sharing their patterns and following their body’s cycles manually with the help of their Oura Rings. Now, they have announced a new feature that helps to accurately track your period.

Though not available at launch, Oura users will also have access to educational content on topics like medication and sleep, workout heart rate recording, improved sleep-tracking accuracy, and blood oxygen (SpO2) monitoring during sleep. The educational content and workout heart rate features will be available later this year, and the sleep and blood oxygen tracking will come in 2022.

Read more: Oura, WHOOP, BioStrap and BioIntelliSense Invading Health Monitoring Space With Biometric Wearables

What’s Unique About Oura’s Approach?

Period Prediction Beta helps you track your period according to your body rather than your calendar. Because there are unique changes that occur in body temperature across the menstrual cycle, body temperature is the key biosignal used to accurately track, predict, and visualize your monthly cycle. During the menstrual cycle, body temperature tends to decrease during the first half (i.e., follicular phase). Ovulation, which typically takes place during the midpoint of your cycle and marks the transition from follicular to luteal, causes body temperature to sharply increase. Body temperature will usually remain elevated throughout the second half of the cycle (i.e., luteal phase). During menstruation, or your period, body temperature will decrease because of an estrogen surge that takes place, reports Oura.

Oura’s hardware capabilities enable precise and consistent measurement of body temperature, granting us the opportunity to capture your unique alternating patterns and reflect them back to you. Worn 24/7 on your finger, Oura enables a reliable digital diary for tracking and educating on your personal menstrual cycle patterns. Your Period Predictions from Oura are built from comprehensive data that builds over time, not single intakes.

All bodies are vastly different and menstrual cycles change not only from person to person but also from cycle to cycle. Women, especially, have many physiological changes that occur in their bodies over the course of a lifetime. Because Oura collects temperature data on a continuous basis, all cycle types—long, short, and highly variable—can be tracked and taken into account when making predictions for one unique person. Our personal body temperature patterns and cycles are intimately linked and highly variable for a reason; they’re tailored down to the individual level, which is why Period Prediction at Oura goes beyond taking the one-size-fits-all approach.

Read more: How Wearables Like Oura and Whoop Became Pandemic Lifestyle

How It Works

Oura predicts your period start date by tracking patterns in your natural body temperature variation over the course of your cycle. Keep in mind, you’ll need at least two months’ worth of consistent temperature data recorded in the Oura app for personal body temperature to be used in predictions. If you’re still in the process of accumulating your 60-day temperature baseline, or if your natural variation can't be detected due to contraceptive use or other hormonal changes, predictions will be based on your last period, cycle length, and regularity.

Zeit Medical, a Redwood City, CA-based startup that makes early warning systems for strokes during sleep, has raised $2 million in seed funding. The funding round was co-led by SeedtoB and Digilife, with participation from Y Combinator, Northsouth Ventures, Gaingels, Axial, Tamar Capital, Citta Capital, as well as angels Greg Badros, Theodore Rekatsinas, and a few others in the healthcare business.

The company said it will use the money to expand operations, build the team, and apply for FDA approval.

Read more: Ultrasound Wearable Patch Could Provide Early Warning for Heart Attacks and Strokes

“This funding will enable us to conduct our clinical studies and pursue FDA clearance,” said Orestis Vardoulis, Zeit Medical co-founder and CEO. “We’re excited to partner with SeedtoB Capital given their unique expertise in the clinical AI space and their shared belief in our vision to improve care and quality of life for anybody at risk for stroke.”

“Stroke remains a leading cause of death in the U.S., and millions of at-risk Americans fear experiencing a stroke when asleep or alone. The Zeit Medical team is tackling this issue with an innovative platform that will not only help improve outcomes but also the quality of life. We’re thrilled to partner with them on this journey,” said Ritesh Sharma, managing partner at SeedtoB Capital. Zeit’s wearable device is a soft headband with a lightweight electroencephalogram (EEG) in it. It works with a smartphone app to analyze brain activity and, using a machine learning model trained by human experts, watch for signs of an impending stroke.

Co-managing partner at Digilife Fund, Bobba Venkatadri, adds, “As science identifies ever more risk factors for stroke, breakthrough risk management options utilizing algorithms and AI have become of paramount importance. Zeit is at the forefront of a global effort to minimize preventable disability and suffering.” The device could be available as early as 2023.

Read more: MIT Researchers Develop Touch-Sensing Glove That May Help In Stroke Recovery

About Zeit Medical

Zeit Medical is an early-stage medical technology company combining the power of wearable sensors and AI to provide immediate at-home stroke detection. More than 90% of strokes in the U.S. go untreated each year, leading to lifelong disabilities and financial burdens for stroke survivors. Zeit Medical was founded by Orestis Vardoulis, a biomedical engineer and digital health expert, and Urs Naber, a critical care physician, after seeing the devastating effects strokes had upon their families. They began addressing this unmet clinical need during their Stanford Biodesign Innovation Fellowship. The company participated in the YCombinator S21 batch.

Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest-monitoring device.

Read more: Biobeat Receives CE Mark for its Patch and Wristwatch for Vital Signs Monitoring

As blood pressure (BP) measurement has shown to be crucial in the early detection and prevention of clinical disorders, ABPM can act as a decisive indicator of patient health, tracking patient cardiac data continuously in real-life settings outside of the physician's office to provide an accurate, holistic and unbiased view of patient health. Biobeat's ABPM solution is currently the only cuffless ABPM application in the world; in addition to retaining patient comfort while enabling the continuation of an uninterrupted daily lifestyle, this solution revolutionizes the logistical workflow of the ABPM test, as each disposable, sterile monitor is delivered directly to the patient's home via courier.

"As healthcare continues its digital transformation, the use of ABPM technologies has become increasingly ubiquitous across the healthcare spectrum, and will continue its growth trajectory as we venture further into the post-COVID-19 era," said Arik Ben Ishay, CEO of Biobeat. "Biobeat is excited to support this positive trend with our new wearable ABPM solution, giving providers a continuous and accurate real-life view into patient cardiac health, replacing antiquated cuff-based technology."

Biobeat's disposable wearable chest monitor includes an easy and intuitive patient self-set-up, requiring no assistance from a clinician or technician. The device measures diastolic and systolic BP, as well as heart rate, mean arterial pressure, cardiac output, and systemic vascular resistance. Measurements are accessible via the patient's mobile phone via a designated app and are also readily available for physicians through an online report-analysis web application. By utilizing the wide range of vital signs measured by the Biobeat device, the report enables healthcare providers to gain a profound understanding of the root cause of the issues identified and truly personalize medicine, allowing for more precise prescription and titration of medications and therapies, says a press release.

The new product launch is supported by a recently published peer-reviewed clinical study. The study, which compared Biobeat's wearable wrist-monitoring device to a standard cuff-based ABPM device, found that Biobeat's device has ABPM monitoring capabilities comparable to the standard cuff-based ABPM device. Findings also demonstrated standard cuff-based ABPM devices resulted in higher blood pressure values, likely due to a startling effect resulting from the inflating cuff, and that Biobeat's wireless wrist monitor caused significantly less inconvenience compared to the cuff-based device. Additionally, the study demonstrated a 24-hour bias of -1.1 mmHg for both diastolic blood pressure (DBP) and systolic blood pressure (SBP), with a mean daytime bias of -1.9 mmHg for DBP and SBP, and an even smaller nighttime bias was determined.

Read more: Fitbit Wearables May Soon Start Measuring Your Blood Pressure

"In addition to systolic and diastolic BP, Biobeat's novel ABPM device measures cardiac output, stroke volume, heart rate, mean arterial pressure, and systemic vascular resistance, providing a comprehensive clinical understanding of an individual's health status," added Professor Arik Eisenkraft, MD, Chief Medical Officer of Biobeat. "This clinical study highlights the benefit of our device over commonly-used cuff-based ABPM devices, with a remarkable ease-of-use and lack of bias resulting from the mechanical effects of the inflating cuff."

Wearables may be able to detect flu even before a patient begins to show symptoms, according to a new study in JAMA.

The study, conducted by researchers at Duke University, showed that a wristband with biometric sensors could detect an influenza infection (H1N1). For the study, the team employed the Empatica E4 wristband, a medical-grade wearable device that measures heart rate, skin temperature, electrodermal activity, and movement in real-time.

Read more: Wearables Can Detect COVID-19 and Even Signs of Depression, Fitbit CEO Tells Axios

"Approximately 9% of the world is infected with influenza annually, resulting in 3 million to 5 million severe cases and 300 000 to 500 000 deaths per year. Adults are infected with approximately 4 to 6 common colds per year, and children are infected with approximately 6 to 8 common colds per year, with more than half of infections caused by human rhinoviruses (RVs),” the researchers wrote. “Given the highly infectious nature of respiratory viruses and their variable incubation periods, infections are often transmitted unwittingly in a manner that results in community spread, especially as no presymptomatic screening methods currently exist to identify respiratory viral diseases. With the increasing emergence of novel viruses, such as SARS-CoV-2, it is critical to quickly identify and isolate contagious carriers of a virus, including presymptomatic and asymptomatic individuals, at the population level to minimize the viral spread and associated severe health outcomes.”

In this study, the researchers recorded biometric data from young people before and after they were inoculated with H1N1 influenza and human rhinovirus.

In the first study, which involved 31 participants inoculated with influenza, Empatica's E4 wristband detected the difference between infection and non-infection with up to 92% accuracy. The second phase involved 18 participants inoculated with human rhinovirus, and here the E4 wristband detected the difference between infection and non-infection with 88% accuracy, reported principal investigator Jessilyn Dunn, Ph.D., of Duke University in Durham, North Carolina, and colleagues.

“This cohort study suggests that the use of a noninvasive, wrist-worn wearable device to predict an individual’s response to viral exposure prior to symptoms is feasible,” the authors of the study wrote. “Harnessing this technology would support early interventions to limit the presymptomatic spread of viral respiratory infections, which is timely in the era of COVID-19.”

Read more: Wearable Freeze-Dried Cell-Free Face Masks for COVID-19 Detection

“We hope to learn what sickness with COVID-19 looks like at the physiological level, and how parameters around heart rate, sleep, and movement change when a person gets infected,” explains Dunn. “We are also interested in comparing data from unvaccinated individuals, as well as people who develop breakthrough infections.”

Respira Labs, a leading respiratory healthcare tech company, has recently announced an AI-powered wearable lung monitor. The wearable could help with early diagnosis and management of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19.

Read more: Noninvasive Wearable Sensors to Advance Chronic Respiratory Disease Management In Patients Around the World

The chest wearable Sylvee 1.0 is a complete, clinical-grade respiratory health wearable providing 2 weeks of non-stop monitoring.

“Well-established science shows that air trapping can be measured with more than 90% accuracy using low-frequency sound. There is a clear difference in the acoustic resonance spectra of COPD patients versus healthy controls,” explained Dr. Maria Artunduaga, Respira Lab’s founder and CEO. “With more than 100 million Americans affected by COPD, COVID-19, and asthma, and with an aging population, it can be lifesaving to remotely and accurately monitor lung function and discover a problem early enough to avoid serious consequences. Our goal is to flag abnormalities early, enable earlier treatment at home and empower patients to manage their own health.”

Sylvee monitors your pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature around the clock for 2-weeks to deliver actionable insights on how you can optimize your day-to-day respiratory health.

Since the pandemic, respiratory diseases have become the #1 cause of death in the U.S. and expenses. It's estimated that 10% of the world's population will be affected by a chronic respiratory disease by 2030.

Read more: S3 Connected Health Deploys Tool For Assessing COVID-19 Risk of Respiratory Deterioration

The standard of care today relies on heavily biased questionnaires and inaccurate pulse-oximeters, missing 50% of respiratory exacerbations leading to very expensive hospitalizations ($19,000 to $50,000) and early deaths (one out of two COPDers hospitalized today will die within the next two years), according to Repira Labs.

Respira's ground-breaking wearable patch uses audible sound to accurately measure trapped air.

Sylvee is named after Artunduaga’s grandmother, who suffered from COPD and died after symptoms quickly worsened without detection.

AMF Medical announced that its Sigi™ Insulin Management System, for diabetes treatment, has been granted Breakthrough Device Designation by the US Food and Drug Administration. Sigi is the only insulin patch pump for closed loop integration designed for use with standard, pre-filled pump cartridges.

Read more: Scientists Develop Ingestible Robot That Delivers Insulin Without The Need For External Needles

Sigi can be programmed to deliver basal and bolus insulin at both set and variable rates. In addition, as an Alternate Controller Enabled-pump, it is able to receive, execute and confirm dosing commands by interacting with Bluetooth-compatible, continuous glucose monitors and alternate controller devices, like a smartphone or an iController, the company said in a press release.

Sigi is also smaller, lighter, and more convenient than current insulin delivery systems. This is made possible by its ergonomic design, which accommodates standard, insulin pre-filled pump cartridges.

AMF Medical Co-CEO and Co-Founder Mr. Antoine Barraud said: “We would like to thank the FDA for recognizing our team's proprietary, patient-focused technology, which provides users with enhanced clinical and convenience features. This Breakthrough Device Designation will expedite the development of Sigi and prioritize its review in future FDA regulatory submissions. It is a huge step forward in bringing Sigi to market to improve insulin management.”

“Clinical study data has shown that Sigi is delightfully easy to use. Study patients have expressed satisfaction as well as eagerness for this next-generation patch to be readily available. We are pleased that the FDA also sees its clear value and is moving the process forward,” said Professor A. Wojtusciszyn, MD, Ph.D. from Lausanne University Hospital (CHUV) and principal investigator of the first Sigi clinical study.

Read more: Medtronic Launches Smart Insulin Pen with Real-Time CGM Data For People on Multiple Daily Injections

About AMF Medical

Originally founded in 2014 in the Swiss Medtech Valley, AMF Medical is developing a novel technology to address the unmet needs of people on insulin therapy. The company's flagship product, Sigi, is a next-generation, plug 'n go, semi-reusable, and rechargeable patch pump, designed to make life easier for people with diabetes. Sigi is intended for prescription use only and is not yet FDA Cleared nor CE-marked. AMF Medical is led by Co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, Ph.D. who is also a Co-Founder. Diabetes industry experts John Timberlake and Peter Gerhardsson serve on the company's Board of Directors.

In the near future, microfiber- and nanofiber-based technology may be used to monitor your blood pressure, heart rate, and more, say researchers. For example, a shirt made with microfiber or nanofiber could monitor your blood pressure or a of socks made with these components could keep track of your cholesterol levels.

Read more: Smart Textile Fibers Powered By Soft Transmission Lines Measure Wearer’s Health

In an article published in Applied Physics Reviews, researchers examined the use of microfibers, and even smaller nanofibers, as wearable monitors that could keep track of a patient's vital signs.

The microfiber- and nanofiber-based technology addresses growing concerns in the medical community about monitoring chronic illnesses like diabetes, asthma, obesity, and high blood pressure as the population ages, reports American Institute of Physics.

“Therefore, the demand for a personalized health care system which detects users' bio-signals at any given location and time is rapidly growing,” said author Rituparna Ghosh.

The wearable fibers are highly sensitive and flexible and can be used to gauge blood pressure, heart rate, sleep quality, cholesterol levels, oxygen levels, and other vital signs. Because of their small size, they can be applied directly to the skin or woven into garments like shirts, socks, neckwear, or wristbands.

“You could have watches. You could have tattoos. It is usable in almost any form,” said Ghosh. “You could have something like a face mask. It could be a handkerchief which you put on your wrist and it starts giving data.”

Author Seeram Ramakrishna, from the National University of Singapore, said one of the most promising nanofiber technologies—piezoelectric sensors, which are powered by mechanical energy—could be ready to go to market in less than three years.

Other technologies, he said, may be ready for public use in anywhere from five to eight years.

Between now and then, Ramakrishna said more research needs to be done on making the fiber sensors more durable, so they can be used repeatedly and coming up with a power source for them that is both reliable and portable. It also will take time, he said, to assure the medical community that the technology is accurate, and its data can be trusted for use with real-world patients.

Read more: MIT Engineers Create Pressure-Responsive Smart Fibers That Change Color to Show Bandage Pressure

“The medical community is always skeptical, while the wellness industry already is using these concepts,” he said. “We need a lot more cause-and-effect studies. We need to amass information so doctors will really accept that this is information they can rely on.”

The global market value of wearable technology was estimated to be more than $32 billion in 2019 and is expected to jump to as much as $74 billion by 2025 as new applications continue to emerge.

In the wearables sector, the mantra is always smaller and smaller components but with greater and greater functionality. As such, when charged with meeting manufacturing challenges that are always exacting, it is vital that companies like Accumold keep on top of the technological opportunities that exist to meet these challenges.

The traditional route to market for miniaturized wearable parts and components is via the tried and tested micro molding process, an enabling technology that has for many years stimulated innovation, and which has produced truly amazing miniature parts, or larger parts with micron features. Micro molding in the right hands can produce fantastic results, and attain extremely tight tolerances repeatable.

But for many years there has been an alternative production process knocking at the door across industry, namely 3D printing / additive manufacturing (AM). Today, many industry sectors have incorporated AM into their manufacturing facilities, often using it as a process that is complementary to existing legacy processes, AM having a unique set of characteristics that make it compelling for some particular applications, or for certain volumes. However, AM processes have never been an option when micro manufacturing, as they are unable to attain the micron level tolerances, and do this in a repeatable fashion. That is until recently!

Today, Accumold has become the first micro molding company to incorporate the Nano Dimension Fabrica 2.0 micro AM technology into its facilities. The Fabrica 2.0 is the first AM process to be able to achieve 1 micron tolerances, and to produce end-use products at volume that are consistent and accurate. As such it opens up for the first time the benefits of AM to the micro manufacturing sector.

And what are these benefits. Well micro AM is much more agile and flexible than traditional alternative micro manufacturing technologies, the requirement for no tooling meaning that designs can be altered with little expense, and the potential for mass customization is now open to players in the wearables sector.

Through the use of a micro AM, manufacturers can also optimize workflow, the technology producing less scrap and fewer tools than conventional manufacturing processes. It also promotes the reduction of iterative process, assembly, and inventory. This means that significant operational cost benefits are now attainable at the micro manufacturing level.

While the Fabrica 2.0 micro AM process can cater for high volume applications (multiple thousands of small parts and components fitting easily in the machine’s build envelope), the introduction of a 3D printing solution for micro manufacturers also means that OEMs are able to reduce the reliance on economies of scale, as the technology makes full production runs measured in thousands as inexpensive as producing one. The Fabrica 2.0 makes low to medium-volume production runs possible that have previously been uneconomical due to the high tooling and set-up costs associated with traditional manufacturing alternatives.

So, the sky is really now the limit when it comes to creativity in the design and manufacture of micro plastics parts for wearables. AM is relatively agnostic to geometric complexity, and so is a spur to innovation, and with micro molding and micro AM both now able to achieve micron tolerances, runs from 1 – 10 million are now as economical as each other when it comes to cost per part.

Core Body Temperature (CBT) is a vital metric of our body and thus a critical parameter for health tracking, remote patient monitoring, and sporting performance enhancement. Although various invasive thermometer alternatives exist to measure CBT, greenTEG is the first company that has developed a continuous, highly accurate, and non-invasive CBT monitoring solution based on heat flux sensing technology, allowing it to compensate for thermal influences from the external environment.
The functionality and accuracy of greenTEG’s CBT sensor have been proven in multiple studies and by the popularity of greenTEG`s first B2C product, the CORE sensor, which is built around this technology.
After the success of the CORE sensor, greenTEG decided to newly brand their technology as CALERA® and also to make it more easily available for OEM customers as they intend to integrate it into their own products.
Under the new brand CALERA®, greenTEG is branding the combination of I) its miniature proprietary thermal energy transfer sensing element (gSKIN®), II) a skin temperature sensor, and III) an AI-based algorithm to enable real-time, continuous, and non-invasive CBT monitoring. Overall, this enables a much easier, compact, and energy-efficient integration into consumer and medical wearable devices. Indeed, with minimal footprint, power, and memory consumption, the CALERA® solution can be integrated into any wearable device and applied to numerous positions on the body.
In this regard, greenTEG is proud to also announce its collaboration with Myant Inc., a global pioneer and leader in textile computing, that integrated CALERA® into their Skiin smart textile monitoring system.
Lukas Durrer, CTO & Co-Founder, says: “CALERA® is key for us to easily start collaborating with OEMs and to partner for integrating our technology. In the long run, CALERA® will be the outstanding branding that will guide consumers to trustworthy wearables which offer non-invasive core body temperature monitoring.”

CALERA® Development Kit launch during Medica trade fair

CALERA® is ready to integrate into any wearable product: the integration into customer wear-able devices is facilitated through a dedicated Development Kit offer, designed specifically for the rapid development and prototyping of a CBT monitor. It explains the procedure for electrical and thermo-mechanical integration and includes all the necessary components to build your own first prototype. Since every device is specific and every use case has its own requirements, greenTEG offers two available versions, one for wrist-worn devices and one for devices worn on the chest. These are to be viewed as tentative approaches to yield the most timely and efficient results, not as definite plans; green-TEG will aid in the detail-defining process during the consulting hours offered in the package. By using the provided integration package, a customer has full cost control and a fast and efficient way to build their customized minimum viable product (MVP).

New use cases for wearables

This approach, combining a heat-flux sensor, skin temperature sensor, and algorithm, results in a robust CBT signal; this method was tested through various case studies to ensure the designed solution successfully supports real-world applications. Real-life applications range from monitoring the Circadian cycle, Ovulation detection, and Patient monitoring of fever symptoms to last but not least, sports applications (i.e. heat adaptation).
Furthermore, CALERA® is currently tested through CORE at several hospitals. At the University hospital in Basel, CORE measurements are compared to the ones collected via standard ear thermometers at the Covid station and, at the University Hospital of Trieste, the same comparison is conducted on stroke patients. The first results of both studies are showing that CORE provides a similar (in certain cases better) accuracy than tympanic thermometers commonly used in hospitals.

About greenTEG

Founded in 2009 as a spin-off of the Swiss Federal Institute of Technology (ETH), greenTEG develops, manufactures, and markets thermal sensors and provides consulting on the thermal integration of its products. Its team consists of 30+ specialists in various engineering disciplines, with all sensors fully developed and manufactured in Zurich, Switzerland.

Today, greenTEG supplies original equipment manufacturers (OEMs) and corporate/university labs around the world with its unique products.
For any press, sales, or marketing information: holger.hendrichs@greenteg.com, +41 445150915

Germany has a long history of watchmaking, with the towns of Glashutte in Saxony and Pforzheim and Schwennigen in the Black Forest becoming renowned hubs for fine watches and horology innovation during the 18^th century. That tradition continues today, with many German firms considered among the world’s leading brands.

Read more: Popularity Of Wearables As A Payment Method Driving Its Market Growth, Poised To Reach $35.48 Bn During 2020-2024

Now, for the first time, Deloitte has published its German Watch Study, a spin-off of the Deloitte Swiss Watch Industry Study.

The study identifies five critical trends and drivers for the German watch industry that will determine its growth path over the coming decades:

1. Bridging the online/offline chasm

Social media and influencers are rapidly replacing traditional media as the channels with the most significant impact on consumers in terms of their watch purchases. Accompanying this development, a generational divide in purchasing behavior is emerging: younger consumers tend to buy online, whereas older generations prefer physical stores. To bridge this divide, firms need to develop omnichannel marketing and sales strategies. 54% of Generation Z respondents pay attention to social media and influencers, the Deloitte study revealed.

2. Price-conscious consumers

Compared to other countries, German consumers are highly price-sensitive. More than 60 percent of respondents were unwilling to pay more than € 250 for a watch. A silver lining is that younger Germans tend to buy watches more frequently than older consumers.

‍

‍

3. Smartwatches triumph

The global demand for smartwatches is growing exponentially, despite the impact of COVID-19. Younger consumers increasingly want digital wristwear with functions to track their fitness and health. Generation Y and Z, in particular, like the convenience of smartwatches for contactless payments. The study also found that 75% of smartwatch owners wear their smartwatches daily.

4. Attracting new luxury customers

Innovative approaches are needed to expand the luxury market, including ideas such as offering financing plans, providing watch rentals, and participating in the pre-owned watch sector. These options all offer an entryway to the luxury market – especially for younger consumers. The study found that 23% of consumers would consider renting a watch.

5. Rising green pressure

Consumers are increasingly aware of sustainability and environmental impact issues and consider these factors when buying a watch. For Generation Z, this is a key factor in their purchasing decision. Watchmakers must ensure that raw materials are ethically sourced and that the carbon footprint of the production process is considered. According to the study, 48% of Generation Z is concerned that raw materials are ethically sourced and 32% of baby boomers prefer less or recycled packaging.

Read more: Global Medical Wearables Market Size to Reach US $85.6 Billion by 2027: Polaris Market Research

Conclusion

While the shifting distribution landscape and changing consumer behavior and attitudes present challenges to the German watch industry, they also create opportunities. The response during the pandemic shows that vitality and creativity remain the foundation of the industry. Therefore, German watchmakers and retailers should continue to be agile and innovative, putting customers at the center of their strategy and operations to seize the potential offered by this phase of accelerated transformation.

Qualcomm Technologies, Inc. started a new initiative meant to bring experts together to develop ideas, further standards, and expand the ecosystem, called the Wearables Ecosystem Accelerator Program.  NXP is a strong supporter of the initiative that involves more than 60 ecosystem players, reports Cyril Caillaud and Love Khanna in the NXP blog.

In addition to this NXP and Qualcomm Technologies, Inc. are expanding their collaboration to now also integrate NXP’s eSIM solutions to wearable devices based on Qualcomm’s widely adopted Snapdragon Wear platform. To lower the integration effort for developers, NXP’s SN110U comes pre-integrated into the latest Snapdragon Wear 4100+ platform. Offering fast transaction speed in an ultra-small format that consumes very little power, the SN110U is ideally suited for use in wearable devices.

Read more: Qualcomm Adds aptX Lossless, New Bluetooth Lossless Audio Technology To Its Audio Portfolio

Developers working on Snapdragon Wear 4100+ benefit from the unique monolithic solution featuring an eSIM, next to NFC for transit, access control, and contactless payments, and an embedded secure element (eSE) to secure services and data – all embodied in the SN110U, according to the NXP blog post.

“The wearables industry is buzzing with rapid growth and unprecedented innovation in the industry,” said Pankaj Kedia, senior director and global head, Smart Wearables Segment, Qualcomm Technologies, Inc. “The Wearables Ecosystem Accelerator Program, which we announced earlier this summer, provides a vehicle for leading players in the wearables space to invent, innovate and invest in next-generation products and accelerate the ecosystem. We welcome NXP to the program and look forward to advancing eSIM-based connected use cases with mobile payments in collaboration with NXP.”

Benefits of these new cellular connectivity capabilities include:

Easier logistics – Eliminating SIM cards simplifies the supply chain for wearables, since there’s one less item to manufacture, transport, warehouse and manage. It saves resources and lowers overall costs.

More streamlined design – Wearables tend to be small, lightweight devices that have a small footprint. An eSIM uses less space than a traditional SIM, so the design is easier to optimize for tight spaces and battery operation, and the bill of materials is lower, too. Also, since there’s no need for a SIM slot, the design can be sleeker and more resistant to water, dust, and other destructive elements.

Better user experiences – The eSIM can receive updated profiles at any time and can store multiple profiles at once, so consumers can add backup profiles or travel internationally without having to change the SIM cards in their wearables.

Faster scaling and easier customization – Wearables can scale more easily across geographic regions that use different service providers, and late-stage customization becomes easier since the eSIM can accept profiles at any point in its life cycle, before or after the sale.

Dynamic security – Updates can be sent to the wearable over the air as needed, even after it’s in the field. Developers can address new threats as they arise and revise algorithms to reflect new approaches as they become available.

Read more: Quectel, Qualcomm and Microsoft Partnership to Speed Up IoT Solutions

The combination of pre-integration and collaboration among the key ecosystem players promises to unlock a new generation of wearable devices.

Mason, a Seattle-based startup formed in 2015, takes its provides the entirety of the hardware – an operating system, and the route to the cloud. Last week, the company announced the market’s first smartwatch designed for the enterprise that can be customized for dedicated use cases including patient monitoring, hospitality, fitness or employee safety.

Read more: zGlue’s Platform zOrigin Lets You Customize Your Own Wearable

Unlike traditional smart devices developed for consumers, the Mason A4100 smartwatch provides a blank slate for innovators to build enterprise-class smart device products for dedicated use cases, without limits to feature and software customizations. Entrepreneurs, startups, and large enterprises can leverage the Mason A4100 smartwatch form factor to quickly bring to market the industry’s first wrist-worn smart devices optimized for the enterprise and customized for a wide variety of use cases, without large upfront capital expenditures. Mason’s curated supply chain accelerates time-to-market and provides a high level of reliability and security, reports Mason.

“We designed the Mason A4100 smartwatch to be the first device to leverage hardware as building blocks—meaning customers have complete flexibility to build and customize the device to fit their exact specifications, regardless of their use case or industry-specific needs,” said Jim Xiao, founder and president of Mason. “By leveraging Mason’s hardware and infrastructure, innovators can go from idea to product launch in a few months—instead of years.”

Mason A4100 Smartwatch Unlocks Wide Range of New Smart Device Use Cases with Advanced Features and Built-in Sensors

The A4100 smartwatch is the newest form factor that builds on the Mason Smart Device Platform. Entrepreneurs, startups and large enterprises can use the Mason A4100 to build a single device for development purposes and scale up to hundreds or thousands of devices as needed. This eliminates minimum order requirements from ODMs (original device manufacturers) that can place a significant financial burden on companies looking to launch new dedicated devices.

Features including significant battery capacity with double the battery life from a single charge compared to other smartwatches on the market, as well as a removable strap, make the Mason A4100 an ideal device for a variety of non-wearable use cases such as wall-mounted thermostats, motion detector alarms and location tracking for pets or children.

The Mason A4100 smartwatch also offers GPS capabilities, advanced algorithms, and numerous built-in biometric sensors such as an electrocardiogram (ECG), photoplethysmogram, temperature sensors, accelerometer, and gyroscopes. These sensors can deliver insights for healthcare and fitness applications and support a variety of use cases including:

• Fall detection for senior care
• Heart rate, heart rate variation, abnormal heart rate conditions, respiratory rate, and blood oximetry detection
• Wellness metrics including stress and energy expenditure at active and resting modes
• Location tracking
• Episodes of acute psychological stress
• User identification by comparing a person’s ECG signal profile against the person’s own ECG signal collected at an earlier time

“Health and care delivery evolution is accelerating. The need for wellbeing, precision medicine, virtual care, and remote patient monitoring will drive innovation in hardware devices to complement exponential growth in applications,” said Rohan Kulkarni, Vice President of Healthcare Research at HFS Research. “Rapid cycles from need recognition to functional delivery is critical and those that can deliver chassis to services to product will play a defining role.”

Read more: New Trend Is Buying Smart Electronics You Customize To Function, Says IDTechEx Report

Mason’s fully customizable OS ensures easy device setup; unprecedented API, feature and security controls; and the ability to adapt or integrate Mason to existing tooling and workflows. It gives users the ability to customize everything from the application’s software to how the fleet of smart devices is remotely managed. With the Mason Smart Device Platform, product owners can effortlessly add, remove or lock down device capabilities to build products as envisioned.

It seems like Apple is studying ways to make AirPods into a health device, which may enhance hearing, monitor body temperature, and posture.

According to a report published in the Wall Street Journal, it isn’t clear if Apple is developing specific new hearing-aid features for AirPods or wants to market the earbuds’ existing hearing-improvement features as hearing aids.

Read more: AirPods 2 Rumor Suggests Inclusion of Biometrics and Wellness Sensors

Furthermore, the WSJ report also suggests that these health-focused features may actually take a while before rolling out in the market. "These functions aren't expected by next year and might never be rolled out to consumers, or the timing could change," the report stated.

The tech giant is already developing prototypes for AirPods to take wearers’ core body temperature from inside their ears, according to the documents reviewed by the Journal. The thermometer would be the second that Apple could add to its devices, including a new wrist temperature-sensor Apple may include in next year’s version of the Apple Watch, the Journal previously reported.

The primary clinical management intervention for people with hearing loss is hearing aids, however, the majority (80%) of adults aged 55–74 years who would benefit from a hearing aid, do not use them. The reasons include hearing aid value, device factor, appearance, fit and comfort and maintenance of the hearing aid, etc.

Offering AirPods as hearing aids could encourage more and more people with hearing loss to start using hearing aids. U.S. Food and Drug Administration (FDA) is working on new regulations that would permit the sale of a new class of cheaper hearing aids directly to consumers to treat mild to moderate hearing loss, according to the Wall Street Journal report. The new regulations are expected to be completed next year.

Read more: Verizon BlueJeans Telehealth Integrates with Apple Health To Streamline Patient Care

Earlier this month, Apple India unveiled its Festive offer during the religious ceremony of Durga Puja. The offer entitles those who buy an iPhone 12 or an iPhone 12 mini via Apple’s online stores to get a free pair of AirPods.

Garmin introduced the Dexcom Connect IQ app, providing people with Type 1 and Type 2 diabetes who use the Dexcom G6 Continuous Glucose Monitor (CGM) System with a way to quickly see their glucose levels and trends – even while working out – right on their compatible Garmin smartwatch or cycling computer. The apps can be downloaded now from the Connect IQ store.

Read more: Dexcom G6 Pro CGM Offers Both Blinded And Unblinded Mode For Glucose Monitoring

“Dexcom’s CGM systems have revolutionized how people live with diabetes, and we are thrilled to offer our customers an even more convenient way to see their glucose levels,” said Dan Bartel, Garmin vice president of global consumer sales. “Users can not only see which way their glucose levels are trending without having to take their phone out but can even do so while working out when glucose levels have the potential to fluctuate quickly.”

The Dexcom Connect IQ apps, developed by Garmin, make it easy for people with diabetes to keep an eye on their glucose numbers at any time, reports Garmin.

During the Day

Available for a wide range of Garmin smartwatches, the Dexcom Connect IQ app provides people with diabetes with a secondary way to view their glucose levels, right from their wrist. With their smartphone stowed away, the app allows people with diabetes to see glucose levels and trends to get a clearer picture of where their numbers are heading, as well as a 3-hour history of glucose levels to look back on.

During an Activity

While out for a run, bike ride, or other adventure, the Dexcom Connect IQ data field provides people with diabetes with a secondary way to view both their glucose levels and performance stats all in one place, so they can focus more on their workout. When training or racing with a compatible smartwatch or Edge® cycling computer, users can keep an eye on their glucose levels and trends, as well as their performance data, right on their Garmin device without pulling out their smartphone.

Read more: Garmin-Lumen Partnership Launches Second Phase Integration With Metabolic Fitness Data

“The addition of Garmin wearables and cycling computers to the Dexcom CGM ecosystem is an exciting advancement for Dexcom users who are now able to easily view and monitor their glucose levels from their favorite Garmin device,” said Jake Leach, chief technology officer at Dexcom. “Garmin is our first partner to connect to Dexcom G6 through our new real-time API – showcasing the value of integrated CGM and further solidifying Dexcom G6 as the most powerful and connected CGM in the world.”

The Dexcom Connect IQ apps are available for download from the Connect IQ Store now for customers in the United States.